PLEASANTON, Calif., Oct. 06, 2017 -- Natus Medical Incorporated (NASDAQ:BABY) today announced that it has completed the acquisition of certain neurosurgery business assets from Integra LifeSciences that was announced on September 11, 2017. The acquisition includes the global Camino ICP monitoring product line, including its San Diego manufacturing facility, and the U.S. rights relating to Integra's fixed pressure shunts, as well as U.S. rights to Codman's DURAFORM® dural graft implant, standard EVD catheters and CSF collection systems.
About Natus Medical Incorporated
Natus is a leading provider of healthcare products and services used in the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, neurosurgery, epilepsy, sleep disorders, and balance and mobility disorders.
Additional information about Natus Medical can be found at www.natus.com.
COMPANY CONTACT:
Natus Medical Incorporated
Jonathan A. Kennedy
Executive Vice President Finance and Chief Financial Officer
(925) 223-6700
[email protected]


China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates 



